Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$499M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
Amazon
AMZN
|
+$286M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$248M |
| 2 |
LPT
Liberty Property Trust
LPT
|
+$148M |
| 3 |
Procter & Gamble
PG
|
+$122M |
| 4 |
Visa
V
|
+$92.4M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
2376
Dynex Capital
DX
$3.22B
| $3.32M | ﹤0.01% |
318,296
+17,519
| +6% | +$289K |
|
2377
NWPX Infrastructure Inc
NWPX
$1.15B
| $3.31M | ﹤0.01% |
148,997
+16,019
| +12% | +$489K |
|
2378
GameStop
GME
$8.57B
| $3.31M | ﹤0.01% |
3,788,924
-1,016,988
| -21% | -$1.09M |
|
|
LAND
2379
Gladstone Land Corp
LAND
$362M
| $3.31M | ﹤0.01% |
279,695
+17,527
| +7% | +$226K |
|
2380
Neurogene
NGNE
$697M
| $3.31M | ﹤0.01% |
14,545
+935
| +7% | +$192K |
|
|
LORL
2381
DELISTED
Loral Space and Communications, Inc.
LORL
| $3.3M | ﹤0.01% |
203,293
+18,433
| +10% | +$537K |
|
2382
Hingham Institution for Saving
HIFS
$659M
| $3.29M | ﹤0.01% |
22,736
+1,678
| +8% | +$314K |
|
2383
Greif Class B
GEF.B
$4.24B
| $3.29M | ﹤0.01% |
82,230
+815
| +1% | +$36.7K |
|
|
SNR
2384
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $3.29M | ﹤0.01% |
1,285,592
+76,504
| +6% | +$488K |
|
2385
Clarus
CLAR
$149M
| $3.29M | ﹤0.01% |
337,163
+19,634
| +6% | +$237K |
|
|
STML
2386
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.29M | ﹤0.01% |
679,533
+59,744
| +10% | +$387K |
|
|
CTO
2387
CTO Realty Growth
CTO
$816M
| $3.29M | ﹤0.01% |
267,097
+14
| +0% | +$218 |
|
2388
Willdan Group
WLDN
$1.24B
| $3.28M | ﹤0.01% |
153,585
+18,685
| +14% | +$576K |
|
|
GNMK
2389
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.27M | ﹤0.01% |
793,144
+31,902
| +4% | +$150K |
|
2390
ADMA Biologics
ADMA
$2.24B
| $3.27M | ﹤0.01% |
1,133,984
+417,376
| +58% | +$1.44M |
|
2391
Cytosorbents Corp
CTSO
$23.6M
| $3.26M | ﹤0.01% |
422,172
+62,520
| +17% | +$316K |
|
2392
Geron
GERN
$982M
| $3.26M | ﹤0.01% |
2,737,256
+263,353
| +11% | +$322K |
|
2393
HUTCHMED
HCM
$2.15B
| $3.26M | ﹤0.01% |
183,521
+25,715
| +16% | +$620K |
|
|
CIR
2394
DELISTED
CIRCOR International, Inc
CIR
| $3.25M | ﹤0.01% |
279,779
+22,138
| +9% | +$779K |
|
2395
Ezcorp Inc
EZPW
$1.7B
| $3.25M | ﹤0.01% |
779,575
+51,143
| +7% | +$263K |
|
2396
Ocular Therapeutix
OCUL
$1.96B
| $3.25M | ﹤0.01% |
656,651
+85,232
| +15% | +$421K |
|
2397
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| – | – |
0
| – | – |
|
|
LCI
2398
DELISTED
Lannett Company, Inc.
LCI
| $3.24M | ﹤0.01% |
116,604
-14,082
| -11% | -$473K |
|
|
OLP
2399
One Liberty Properties
OLP
$528M
| $3.21M | ﹤0.01% |
230,799
+24,325
| +12% | +$589K |
|
2400
Ribbon Communications
RBBN
$376M
| $3.21M | ﹤0.01% |
1,060,809
+283,868
| +37% | +$853K |
|
Similar funds
Geode Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Geode Capital Management held 4,292 positions worth $384B, down 20% from $478B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geode Capital Management's Q1 2020 filing shows 103 new, 3,113 increased, 564 reduced and 177 closed positions. Its largest new stake was Perdoceo Education: 1,042,040 shares worth $11.2M. The largest sale was Wellcare Health Plans, Inc., an estimated $248M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2020 buy was Perdoceo Education: 1,042,040 shares worth $11.2M.
- Geode Capital Management added most to Apple in Q1 2020, an estimated $499M increase.
- Geode Capital Management's biggest Q1 2020 reduction was Procter & Gamble, cutting an estimated $122M.
- Geode Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $248M.
- Geode Capital Management's ten largest holdings make up 21% of its $384B portfolio in Q1 2020.
- Geode Capital Management opened 103 new positions and closed 177 in Q1 2020.
- Geode Capital Management's portfolio value fell 20% quarter-over-quarter to $384B.
Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.